For the quarter ended March 2024, Shockwave Medical (SWAV) reported income of $218.81 million, up 35.8% over the identical interval final 12 months. EPS got here in at $1.44, in comparison with $1.03 within the year-ago quarter.
The reported income compares to the Zacks Consensus Estimate of $207.09 million, representing a shock of +5.66%. The corporate delivered an EPS shock of +38.46%, with the consensus EPS estimate being $1.04.
Whereas traders scrutinize income and earnings modifications year-over-year and the way they examine with Wall Road expectations to find out their subsequent transfer, some key metrics at all times supply a extra correct image of an organization’s monetary well being.
As these metrics affect top- and bottom-line efficiency, evaluating them to the year-ago numbers and what analysts estimated helps traders mission a inventory’s value efficiency extra precisely.
Right here is how Shockwave Medical carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Road analysts:
- Geographic Income- United States: $175.53 million versus $166.54 million estimated by 5 analysts on common.
- Geographic Income- Europe: $26.26 million versus $21.06 million estimated by two analysts on common.
- Geographic Income- All different international locations: $17.01 million versus $19.32 million estimated by two analysts on common.
- Income- Coronary: $164.53 million versus the two-analyst common estimate of $151.51 million.
- Income- Reducer: $1.84 million versus $1.68 million estimated by two analysts on common.
- Income- Different: $0.60 million versus the two-analyst common estimate of $0.47 million.
- Income- Peripheral: $51.84 million in comparison with the $52.78 million common estimate based mostly on two analysts.
View all Key Company Metrics for Shockwave Medical here>>>
Shares of Shockwave Medical have returned +1.2% over the previous month versus the Zacks S&P 500 composite’s -1.6% change. The inventory at the moment has a Zacks Rank #3 (Maintain), indicating that it might carry out in step with the broader market within the close to time period.
Solely $1 to See All Zacks’ Buys and Sells
We’re not kidding.
A number of years in the past, we shocked our members by providing them 30-day entry to all our picks for the overall sum of solely $1. No obligation to spend one other cent.
1000’s have taken benefit of this chance. 1000’s didn’t – they thought there have to be a catch. Sure, we do have a motive. We would like you to get acquainted with our portfolio providers like Shock Dealer, Shares Underneath $10, Know-how Innovators,and extra, that closed 228 positions with double- and triple-digit good points in 2023 alone.
ShockWave Medical, Inc. (SWAV) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
